Kahn Ex Rel. Dekalb Genetics Corp. v. Roberts

679 A.2d 460, 1996 Del. LEXIS 275, 1996 WL 438724
CourtSupreme Court of Delaware
DecidedJuly 25, 1996
Docket9, 1996
StatusPublished
Cited by16 cases

This text of 679 A.2d 460 (Kahn Ex Rel. Dekalb Genetics Corp. v. Roberts) is published on Counsel Stack Legal Research, covering Supreme Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kahn Ex Rel. Dekalb Genetics Corp. v. Roberts, 679 A.2d 460, 1996 Del. LEXIS 275, 1996 WL 438724 (Del. 1996).

Opinion

WALSH, Justice.

Plaintiff Alan Kahn (“Kahn”) appeals the dismissal of his claims of breach of the duties of care and disclosure in connection with a buyback of one-third of the outstanding stock of DeKalb Genetics Corporation (“DeKalb”). Kahn argues that the DeKalb directors’ actions do not withstand the judicial scrutiny required under Unocal Corp. v. Mesa Petroleum Co., Del.Supr., 493 A.2d 946 (1985), and that the board violated its duty of disclosure.

The Court of Chancery correctly held that no enhanced judicial scrutiny of the transaction under Unocal is required. With respect to the disclosure claim, the Court of Chancery ruled that no duty of disclosure arises where the board of directors undertakes to disclose information in a context wherein shareholder action is not implicated. Since the alleged deficiencies are immaterial in any event, we need not reach the issue of the scope of the duty of disclosure, but hold that lack of materiality of the alleged omissions precludes recovery.

*462 Accordingly, the decision of the Court of Chancery is affirmed.

I.

The factual background leading to this dispute is viewed from a perspective which favors Kahn as the party resisting summary judgment.

DeKalb engages in the production and marketing of corn and soybean seed product lines, swine and poultry production, and biotechnology research. It has a dual capitalization structure, consisting of Class A and Class B stock. Class A stockholders and Class B stockholders have the same rights to dividends and other distributions, but Class B stockholders have no voting rights other than required by Delaware law. No national securities exchange trades the Class A stock, but Class B trades on the NASDAQ over-the-counter market. For corporate purposes, DeKalb values the Class A stock at the market price of the Class B stock.

In December, 1990, Thomas Roberts, Jr., Thomas Roberts, III and their families 1 collectively owned one-third of the Class A and Class B stock of DeKalb. In the first half of 1990, John R. Nelson (“Nelson”), the executive manager of one of DeKalb’s business segments, DeKalb Poultry Research, Inc. (“DPRI”), resigned. Thomas Roberts, III headed the international marketing division and showed interest in succeeding Nelson. Bruce P. Bickner (“Bickner”), who was the chairman of the board, and Richard 0. Ryan (“Ryan”), another director, were responsible for selecting Nelson’s successor. They chose someone other than Thomas Roberts, III for the position.

This selection process disappointed Thomas Roberts, III and his father Thomas Roberts, Jr. As a result, they suggested to Bickner and Ryan that the Roberts family would “rethink” its position as large DeKalb stockholders.

Thomas Roberts, III faced further disappointment. After the United States Customs Agency audited DPRI’s international sales in October, 1990, Bickner requested that Thomas Roberts, III resign because of alleged irregularities. Thomas Roberts, III tendered his resignation shortly thereafter, to be effective March 30, 1991. Despite the severance of the employment relationship, Thomas Roberts, III did not leave his position as a director of DeKalb for more than two years after his resignation.

As a result of its disenchantment with DeKalb, the Roberts family determined to reduce or sever its financial ties with the company. In December 1990, Thomas Roberts, Jr. approached Charles Roberts, suggesting the Charles Roberts family purchase the Roberts family stock. Then in January 1991, Thomas Roberts, Jr. proposed to Charles Roberts that the two jointly recommend that the DeKalb board sell the company because, in the view of Thomas Roberts, Jr., DeKalb was financially unable to keep pace with its primary competitor, Pioneer Hi-Bred International, Inc. Charles Roberts was unreceptive to both proposals.

Shortly thereafter, Thomas Roberts, Jr. approached Charles Roberts and Bickner with still another proposal: that DeKalb repurchase the Roberts’ family stock. Bickner sought the assistance of Merrill Lynch & Company to evaluate whether DeKalb should sell itself, the status and effectiveness of DeKalb’s research, the competitiveness of DeKalb’s product line, and the financial future of the company in general. Bickner also retained Shearman & Sterling as legal counsel for DeKalb.

On May 23,1991, the DeKalb board held a special meeting to discuss the concerns Thomas Roberts, Jr. had originally raised about deficiencies in the seed research program. At the meeting, Thomas Roberts, Jr. expressed his view that these failings ultimately would result in loss of DeKalb’s market share and he urged a sale or merger of the company. DeKalb’s head of Plant Genetics gave a presentation rebutting Thomas Roberts, Jr.’s concern. Agreeing with the rebuttal presentation, Bickner expressed his view that current policies had been effective *463 and that DeKalb should remain independent. After deliberating, the board rejected Thomas Roberts, Jr.’s recommendation and passed a resolution, by a vote of nine to three, that it was in the best interest of DeKalb and its stockholders to remain independent. Only Thomas Roberts, Jr., Thomas Roberts, III, and Paul R. Judy (“Judy”) voted against the resolution.

After the board’s rejection of the proposal to sell the company, Merrill Lynch met with financial advisors and attorneys representing the Roberts family concerning the family’s interest in selling their DeKalb Class A and Class B stock.

The full board considered the issue of a possible repurchase of the Roberts family stock at its regular meeting on July 1, 1991. During this meeting, after the Thomas Roberts Defendants departed, the remainder of the board met with Douglas Brown (“Brown”) of Merrill Lynch. Brown supported the repurchase of the Roberts family stock. In addition to this recommendation, Merrill Lynch presented the board with several options, including the possibility of generating a sale of the entire company to a “hostile” outsider and the possibility of a “poison pill” to discourage sale of DeKalb. Consistent with its earlier determinations to maintain DeKalb as an independent corporation, the board sought further consideration of a repurchase of the Roberts family’s shares. Brown advised the board that a repurchase price of $40 per share for the Class A Stock would be a beneficial transaction for DeKalb.

The Merrill Lynch presentation apparently was sufficiently persuasive to prompt the board to consider seriously the repurchase of the Roberts family stock. To that end, at the July 1, 1991 meeting, the board appointed a Special Committee of six outside directors to oversee and to conduct discussions between the Company and the Roberts family. Allan Aves (“Aves”), Charles J. Arntzen (“Arntzen”), Paul F. Cornelsen (“Cornel-sen”), Judy, Nelson, and Blair White (“White”) comprised the Special Committee. This committee was also responsible for recommending to the full board the terms for any repurchase.

Four days later, the Special Committee conducted a telephonic meeting. All directors except the Thomas Roberts defendants participated.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Edgio, Inc. Stockholders Litigation
Court of Chancery of Delaware, 2023
In re WeWork Litigation
Court of Chancery of Delaware, 2020
Walter Ryan, Jr. v. Alan S. Armstrong
Court of Chancery of Delaware, 2017
The Huff Energy Fund, L.P. v. Gershen
Court of Chancery of Delaware, 2016
In re Ebix, Inc. Stockholder Litigation
Court of Chancery of Delaware, 2016
Ryan v. Gursahaney
Court of Chancery of Delaware, 2015
Air Products & Chemicals, Inc. v. Airgas, Inc.
16 A.3d 48 (Court of Chancery of Delaware, 2011)
eBay Domestic Holdings, Inc. v. Newmark
16 A.3d 1 (Court of Chancery of Delaware, 2010)
Crandon Capital Partners v. Shelk
181 P.3d 773 (Court of Appeals of Oregon, 2008)
Pereira v. Cogan
294 B.R. 449 (S.D. New York, 2003)
McMillan v. Intercargo Corp.
768 A.2d 492 (Court of Chancery of Delaware, 2000)
Malone v. Brincat
722 A.2d 5 (Supreme Court of Delaware, 1998)
Wilson v. Tully
243 A.D.2d 229 (Appellate Division of the Supreme Court of New York, 1998)
Potter v. Pohlad
560 N.W.2d 389 (Court of Appeals of Minnesota, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
679 A.2d 460, 1996 Del. LEXIS 275, 1996 WL 438724, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kahn-ex-rel-dekalb-genetics-corp-v-roberts-del-1996.